pamidronate has been researched along with Charcot's Joint in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " They differed markedly in study type, pharmacological agent used, dosing regimen, disease, aetiology/stage/location, concurrent off-loading regimen, outcomes and, follow-up." | 2.49 | A Surgeon's guide to advances in the pharmacological management of acute Charcot neuroarthropathy. ( Afsie, S; Al-Nammari, SS; Timothy, T, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Nammari, SS | 1 |
| Timothy, T | 1 |
| Afsie, S | 1 |
| Molines, L | 1 |
| Darmon, P | 1 |
| Raccah, D | 1 |
| Kumar, N | 1 |
| Cheung, YC | 1 |
| Varughese, GI | 1 |
| Benn, JJ | 1 |
| Willis, AC | 1 |
| Naqvi, A | 1 |
| Cuchacovich, R | 1 |
| Saketkoo, L | 1 |
| Espinoza, LR | 1 |
| Guis, S | 1 |
| Pellissier, JF | 1 |
| Arniaud, D | 1 |
| Turck, F | 1 |
| Witjas, T | 1 |
| Roux, H | 1 |
| Mattei, JP | 1 |
| Jude, EB | 1 |
| Selby, PL | 1 |
| Burgess, J | 1 |
| Lilleystone, P | 1 |
| Mawer, EB | 1 |
| Page, SR | 1 |
| Donohoe, M | 1 |
| Foster, AV | 1 |
| Edmonds, ME | 1 |
| Boulton, AJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Treatment With DENOsumab of an Acute CHARCOT Foot in Patients With Diabetes. A Multicenter, Double-blind, Randomized, Placebo-controlled Trial.[NCT04547348] | Phase 3 | 38 participants (Anticipated) | Interventional | 2020-11-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for pamidronate and Charcot's Joint
| Article | Year |
|---|---|
A Surgeon's guide to advances in the pharmacological management of acute Charcot neuroarthropathy.
Topics: Alendronate; Alkaline Phosphatase; Arthropathy, Neurogenic; Bone Density Conservation Agents; Calcit | 2013 |
Charcot's foot: newest findings on its pathophysiology, diagnosis and treatment.
Topics: Alendronate; Arthropathy, Neurogenic; Biomarkers; Bone Density Conservation Agents; Calcitonin; Diab | 2010 |
1 trial available for pamidronate and Charcot's Joint
| Article | Year |
|---|---|
Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.
Topics: Adult; Aged; Alkaline Phosphatase; Anti-Inflammatory Agents; Arthropathy, Neurogenic; Biomarkers; Bo | 2001 |
3 other studies available for pamidronate and Charcot's Joint
| Article | Year |
|---|---|
Medical image. A sequel of deranged metabolic control. Diabetes mellitus.
Topics: Aged; Anti-Inflammatory Agents; Arthropathy, Neurogenic; Bone Density Conservation Agents; Diabetic | 2008 |
Acute Charcot arthropathy successfully treated with pamidronate: long-term follow-up.
Topics: Aged, 80 and over; Arthropathy, Neurogenic; Bone Density Conservation Agents; Diabetes Mellitus, Typ | 2008 |
Healing of Charcot's joint by pamidronate infusion.
Topics: Adult; Anti-Inflammatory Agents; Arthropathy, Neurogenic; Diphosphonates; Humans; Male; Pamidronate; | 1999 |